"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug last month and lower than expected sales figures from Eli Lilly for two ...